Ugi and Passerini reaction |
4-Aminoquinoline γand δ-lactam |
16 |
Ugi-4C-3CR |
enzymatic; cell: P. falciparum T. brucei
|
compound 1: enzyme: IC50 = 17.62 µM P. falciparum: IC50 = 0.096 µM; compound 2: T. brucei: ED50 = 1.44 µM |
4545 Musonda, C. C.; Gut, J.; Rosenthal, P. J.; Yardley, V.; de Souza, R. C. C.; Chibale, K.; Bioorg. Med. Chem. 2006, 14, 5605. [Crossref] Crossref...
|
Bestatin’s derivative |
24 |
Ugi-4CR and Ugi-5C-4CR |
enzymatic; cell: P. falciparum
|
compound 4: enzyme: Ki = 0.4 µM IC50 in cells: Pf3D7 = 18 µM PfFcB1 = 16 µM |
4646 González-Bacerio, J.; Maluf, S. E. C.; Méndez, Y.; Pascual, I.; Florent, I.; Melo, P. M. S.; Budu, A.; Ferreira, J. C.; Moreno, E.; Carmona, A. K.; Rivera, D. G.; del Rivero, M. A.; Gazarini, M. L.; Bioorg. Med. Chem. 2017, 25, 4628. [Crossref] Crossref...
|
Isomannide derivative |
10 |
Ugi-4CR |
enzymatic |
compound 5: IC50 = 4.0 µM (competitive inhibitor) compound 6: IC50 = 12.6 µM |
4747 Barros, T. G.; Santos, J. A. N.; de Souza, B. E. G.; Sodero, A. C. R.; de Souza, A. M. T.; da Silva, D. P.; Rodrigues, C. R.; Pinheiro, S.; Dias, L. R. S.; Abrahim-Vieira, B.; Puzer, L.; Muri, E. M. F.; Bioorg. Med. Chem. Lett. 2017, 27, 314. [Crossref] Crossref...
|
Peptoid |
13 |
Ugi-4CR |
cell: L. amazonensis promastigotes |
compound 7: IC50 = 2.80 µM compound 8: IC50 = 2.61 µM compound 9: IC50 = 7.90 µM |
4848 Previdi, D.; Rodrigues, S.; Coelho, M. G.; Candido, A. C. B. B.; Magalhães, L. G.; Donate, P. M.; J. Braz. Chem. Soc. 2019, 30, 1334. [Crossref] Crossref...
|
Epoxy-α‑acyloxycarboxamide |
17 |
Passerini |
enzymatic |
compound 10: IC50 = 1.33 µM |
4949 dos Santos, D. A.; Deobald, A. M.; Cornelio, V. E.; Ávila, R. M. D.; Cornea, R. C.; Bernasconi, G. C. R.; Paixão, M. W.; Vieira, P. C.; Corrêa, A. G.; Bioorg. Med. Chem. 2017, 25, 4620. [Crossref] Crossref...
|
Epoxy-α‑acyloxycarboxamide |
5 |
Passerini + Ugi-4CR |
enzymatic |
compound 11: Ki = 5.45 µM compound 12: Ki = 9.57 µM |
5050 Silva, T. L.; dos Santos, D. A.; de Jesus, H. C. R.; Brömme, D.; Fernandes, J. B.; Paixão, M. W.; Corrêa, A. G.; Vieira, P. C.; Bioorg. Med. Chem. 2020, 28, 115597. [Crossref] Crossref...
|
Biginelli reaction |
DHPM |
8 |
Biginelli |
in vitro antioxidant capacity |
compounds 13, 14 and 15: best results |
5151 Stefani, H. A.; Oliveira, C. B.; Almeida, R. B.; Pereira, C. M. P.; Braga, R. C.; Cella, R.; Borges, V. C.; Savegnago, L.; Nogueira, C. W.; Eur. J. Med. Chem. 2006, 41, 513. [Crossref] Crossref...
|
DHPM |
26 |
Biginelli |
in vitro antioxidant capacity; cell: cytotoxicity in seven cancer cell lines |
compounds 16-19: best antioxidant capacity; compound 20 all cancer cells: GI50 < 32.64 µM |
5252 da Silva, D. L.; Fernandes, S. A.; Sabino, A. A.; de Fátima, Â.; Tetrahedron Lett. 2011, 52, 6328. [Crossref] Crossref...
|
DHPM |
14 |
Biginelli |
cell: cytotoxicity in seven cancer cell lines |
compound 21: IC50 = 5.93-20.60 µM |
5353 Russowsky, D.; Canto, R. F. S.; Sanches, S. A. A.; D’Oca, M. G. M.; de Fátima, Â.; Pilli, R. A.; Kohn, L. K.; Antônio, M. A.; de Carvalho, J. E.; Bioorg. Chem. 2006, 34, 173. [Crossref] Crossref...
|
DHPM |
14 |
Biginelli |
cell: cytotoxicity in C6 |
compounds 22-25: highest activities |
5454 Canto, R. F. S.; Bernardi, A.; Battastini, A. M. O.; Russowsky, D.; Eifler-Lima, V. L.; J. Braz. Chem. Soc. 2011, 22, 1379. [Crossref] Crossref...
|
N1-Aryl-substituted DHPM |
22 |
Biginelli |
cell: cytotoxicity in C6 and U138; in vivo toxicity: C. elegans
|
compounds 26 and 27: IC50 = 54.7-142.7 µM; C. elegans: LC50 = 29.80-32.90 µM |
5555 Gonçalves, I. L.; Rockenbach, L.; das Neves, G. M.; Göethel, G.; Nascimento, F.; Kagami, L. P.; Figueiró, F.; de Azambuja, G. O.; Dias, A. F.; Amaro, A.; de Souza, L. M.; Pitta, I. R.; Avila, D. S.; Kawano, D. F.; Garcia, S. C.; Battastini, A. M. O.; Eifler-Lima, V. L.; MedChemComm 2018, 9, 995. [Crossref] Crossref...
|
N1-Aryl-substituted DHPM |
1 |
Biginelli |
cell: cytotoxicity in T24 in vivo toxicity: C. elegans
|
compound 28: IC50 = 10.73 µM; C. elegans: decrease of multivulvas number; C. elegans: LC50 > 600 µM |
1818 Kagami, L. P.; Gonçalves, I. L.; da Silva, Á. C.; Silva, A. C.; das Neves, G. M.; Göethel, G.; Spillere, A.; dos Santos, M. R.; Figueiró, F.; Garcia, S. C.; Ávila, D. S.; Battastini, A. M. O.; Eifler-Lima, V. L.; Chem. Biol. Drug Des. 2023, 102, 536. [Crossref] Crossref...
|
DHPM |
10 |
batch continuous flow Biginelli |
cell: cytotoxicity in three cancer cell lines |
compounds 29-31: induced death > 50% in 72 h treatment |
5656 Silva, G. C. O.; Correa, J. R.; Rodrigues, M. O.; Alvim, H. G. O.; Guido, B. C.; Gatto, C. C.; Wanderley, K. A.; Fioramonte, M.; Gozzo, F. C.; de Souza, R. O. M. A.; Neto, B. A. D.; RSC Adv. 2015, 5, 48506. [Crossref] Crossref...
|
DHPM-fatty acid hybrid (substitution site: C5) |
18 |
Biginelli |
cell: cytotoxicity in C6 in 24 h treatment |
compound 32 reduced cell viability: 50% |
5757 Treptow, T. G. M.; Figueiró, F.; Jandrey, E. H. F.; Battastini, A. M. O.; Salbego, C. G.; Hoppe, J. B.; Taborda, P. S.; Rosa, S. B.; Piovesan, L. A.; D’Oca, C. R. M.; Russowsky, D.; D’Oca, M. G. M.; Eur. J. Med. Chem. 2015, 95, 552. [Crossref] Crossref...
|
DHPM-fatty acid hybrid (substitution site: C6) |
6 |
Biginelli |
cell: cytotoxicity in C6 in 48 h treatment |
compound 33: IC50 = 5.11 µM; compound 34: C6: IC50 = 5.11 µM |
5858 de Oliveira, F. S.; de Oliveira, P. M.; Farias, L. M.; Brinkerhoff, R. C.; Sobrinho, R. C. M. A.; Treptow, T. M.; D’Oca, C. R. M.; Marinho, M. A. G.; Hort, M. A.; Horn, A. P.; Russowsky, D.; D’Oca, M. G. M.; MedChemComm 2018, 9, 1282. [Crossref] Crossref...
|
DHPM-benzazol hybrid |
6 |
Biginelli |
cell: cytotoxicity in three cancer cell lines |
compounds 35 and 36: IC50 < 40 µM; compound 37: IC50 = 10.7-158.7 µM |
5959 de Souza, V. P.; Santos, F. S.; Rodembusch, F. S.; Braga, C. B.; Ornelas, C.; Pilli, R. A.; Russowsky, D.; New J. Chem. 2020, 44, 12440. [Crossref] Crossref...
|
DHPM-cinnamic acids hybrid |
6 |
Biginelli |
cell: cytotoxicity in two prostate cancer cell lines |
compound 38: IC50 = 11.5-51.7 µM; compounds 39 and 40: best activity against prostate cancer cell lines |
6060 Barbosa, F. A. R.; Rode, M. P.; Canto, R. F. S.; Silva, A. H.; Creczynski-Pasa, T. B.; Braga, A. L.; ChemistrySelect 2022, 7, e202200274. [Crossref] Crossref...
|
DHPM |
37 |
ionic liquid catalyzed Biginelli |
cell: cytotoxicity |
the compounds displayed promising cytotoxic profile |
6161 Ramos, L. M.; Guido, B. C.; Nobrega, C. C.; Corrêa, J. R.; Silva, R. G.; de Oliveira, H. C. B.; Gomes, A. F.; Gozzo, F. C.; Neto, B. A. D.; Chem. - Eur. J. 2013, 19, 4156. [Crossref] Crossref...
|
DHPM |
26 |
ionic liquid catalyzed Biginelli |
enzymatic |
compound 41: Ki = 0.96 µM; compound 42: Ki = 0.57 µM |
6262 Braga, T. C.; Silva, T. F.; Maciel, T. M. S.; da Silva, E. C. D.; da Silva-Júnior, E. F.; Modolo, L. V.; Figueiredo, I. M.; Santos, J. C. C.; de Aquino, T. M.; de Fátima, A.; New J. Chem. 2019, 43, 15187. [Crossref] Crossref...
|
DHPM and pyrrolopyrimidinones hybrid |
30 |
Biginelli |
cell: chloroquine resistant P. falciparum; cytotoxicity; in vivo: P. berghei parasitemia reduction in rats |
compound 43: IC50 = 2.98 µM; compound 44: IC50 = 1.76 µM; compound 45: IC50 = 3.12 µM; compounds 43-45: reduce parasitemia in 33-60% (rats) |
6363 Rogerio, K. R.; Carvalho, L. J. M.; Domingues, L. H. P.; Neves, B. J.; Moreira Filho, J. T.; Castro, R. N.; Bianco Júnior, C.; Daniel-Ribeiro, C. T.; Andrade, C. H.; Graebin, C. S.; Mem. Inst. Oswaldo Cruz 2018, 113, e170452. [Crossref] Crossref...
|
DHPM-quinone hybrid |
19 |
Biginelli |
cell: chloroquine resistant P. falciparum
|
compound 46: IC50 = 1.15 µM compound 47: IC50 = 1.5 µM |
6464 Rogerio, K. R.; Graebin, C. S.; Domingues, L. H. P.; Oliveira, L. S.; da Silva, V. S. F.; Daniel-Ribeiro, C. T.; Carvalho, L. J. M.; Boechat, N.; Curr. Top. Med. Chem. 2020, 20, 99. [Crossref] Crossref...
|
Hantzsch reaction |
|
|
|
|
|
1,4-DHP |
14 |
Hantzsch |
in vitro antioxidant capacity cell: cytotoxicity in seven cancer cell lines |
compound 48: SC50 = 30.4-217.5 µM compound 49: SC50 = 31.5-181.8 µM |
6565 Pacheco, S. R.; Braga, T. C.; da Silva, D. L.; Horta, L. P.; Reis, F. S.; Ruiz, A. L. T. G.; de Carvalho, J. E.; Modolo, L. V.; de Fatima, A.; Med. Chem. 2013, 9, 889. [Crossref] Crossref...
|
1,4-DHP and one 1,3-oxazin-6-one |
8 |
Hantzsch |
cell: cytotoxicity in nine cancer cell lines |
compound 51: IC50 = 4.63 µM compound 52: IC50 = 4.10 µM |
6666 Sandjo, L. P.; Kuete, V.; Nana, F.; Kirsch, G.; Efferth, T.; Helv. Chim. Acta 2016, 99, 310. [Crossref] Crossref...
|
PHQ-fatty acids hybrid |
15 |
Hantzsch-4C |
cell: cytotoxicity in C6 |
compound 53: reduced viability in 40% |
6767 Cabrera, D. C.; Rosa, S. B.; de Oliveira, F. S.; Marinho, M. A. G.; D’Oca, C. R. M.; Russowsky, D.; Horn, A. P.; D’Oca, M. G. M.; MedChemComm 2016, 7, 2167. [Crossref] Crossref...
|
Symmetrical and unsymmetrical 1,4-DHP |
42 |
Hantzsch |
in vitro antioxidant capacity |
compounds 54-56: best activities |
6868 Cabrera, D. C.; Santa-Helena, E.; Leal, H. P.; de Moura, R. R.; Nery, L. E. M.; Gonçalves, C. A. N.; Russowsky, D.; D’Oca, M. G. M.; Bioorg. Chem. 2019, 84, 1. [Crossref] Crossref...
|
PHQ-fatty acids hybrid |
18 |
Hantzsch-4C |
in vitro antioxidant capacity |
compound 57: EC50 = 2.11-4.69 µM |
6969 Brinkerhoff, R. C.; Santa-Helena, E.; do Amaral, P. C.; Cabrera, D. C.; Ongaratto, R. F.; de Oliveira, P. M.; D’Oca, C. R. M.; Gonçalves, C. A. N.; Nery, L. E. M.; D’Oca, M. G. M.; RSC Adv. 2019, 9, 24688. [Crossref] Crossref...
|
Hydroquinoline-1,4‑DHPs hybrid |
10 |
microwave assisted modified Hantzsch |
photochemistry in vitro: BSA binding |
photochemistry: absorption maxima region ca. 350 nm BSA binding: strong interaction |
7070 da Luz, L. C.; Gündüz, M. G.; Beal, R.; Zanotto, G. M.; Kuhn, E. R.; Netz, P. A.; Şafak, C.; Gonçalves, P. F. B.; Santos, F. S.; Rodembusch, F. S.; J. Photochem. Photobiol., A 2022, 429, 113915. [Crossref] Crossref...
,7171 Gündüz, M. G.; Albayrak, E.; İşli, F.; Fincan, G. S. Ö.; Yildirim, Ş.; Şimşek, R.; Şafak, C.; Sarioğlu, Y.; Yidirim, S. Ö.; Butcher, R. J.; J. Serb. Chem. Soc. 2016, 81, 729. [Crossref] Crossref...
|
1,4-DHP |
5 |
Hantzsch |
photosystem II fluorescence bioassay |
best compounds: 60 and 61 (reduced fluorescence parameters) |
72 |